Blood Group Typing Market Regional Analysis:
North American Market Insights
North America region is poised to dominate around 42.4% market share by 2035, attributed to the increasing need for blood transfusions, favorable reimbursement policies, and rising chronic disease cases in the region. For instance, nearly 5,000 units of platelets and 6.500 units of plasma are needed daily in the U.S. and Nearly 16 million blood components are transfused each year in the U.S. Furthermore, availability of favorable reimbursement policies, rising cases of chronic diseases many of which require blood type determination for effective treatment, and high prevalence of infectious diseases are expected to drive blood group typing market growth in the region during the forecast period.
APAC Market Statistics Market Insights
On the other hand, the market in the Asia Pacific region is also estimated to hold a significant market share. The massive investments in developing advanced blood group typing technologies along with the presence of a large pool of patients waiting for blood transfusion diagnostics are the major factors for the market growth during the forecast period. Rising healthcare expenditure and improved hospital settings for blood donations also anticipated to bring lucrative growth opportunities for the market.
